Brought to you by 
Innovus gets two OTC compounds from Univ. of Iowa Research Foundation
08 Jun 2017
Executive Summary
The University of Iowa Research Foundation licensed Innovus Pharmaceuticals Inc. exclusive rights to thymol and carvacrol for cachexia and muscle growth and repair.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Innovus gets two OTC compounds from Univ. of Iowa Research Foundation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice